BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30072888)

  • 1.
    Hierro-Bujalance C; Bacskai BJ; Garcia-Alloza M
    Front Aging Neurosci; 2018; 10():218. PubMed ID: 30072888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of microglial cathepsins in neurodegenerative disease.
    Lowry JR; Klegeris A
    Brain Res Bull; 2018 May; 139():144-156. PubMed ID: 29454581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Techniques for brain imaging in vivo.
    Garcia-Alloza M; Bacskai BJ
    Neuromolecular Med; 2004; 6(1):65-78. PubMed ID: 15781977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical characterization of amyloid imaging probes with multiphoton microscopy.
    Skoch J; Hyman BT; Bacskai BJ
    J Alzheimers Dis; 2006; 9(3 Suppl):401-7. PubMed ID: 16914878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive
    Etebar F; Harkin DG; White AR; Dando SJ
    Front Cell Neurosci; 2024; 18():1355557. PubMed ID: 38348116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Fan Z; Okello AA; Brooks DJ; Edison P
    Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
    Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
    Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.
    Cerami C; Iaccarino L; Perani D
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo PET imaging of neuroinflammation in Alzheimer's disease.
    Lagarde J; Sarazin M; Bottlaender M
    J Neural Transm (Vienna); 2018 May; 125(5):847-867. PubMed ID: 28516240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Keller T; López-Picón FR; Krzyczmonik A; Forsback S; Kirjavainen AK; Takkinen JS; Alzghool O; Rajander J; Teperi S; Cacheux F; Damont A; Dollé F; Rinne JO; Solin O; Haaparanta-Solin M
    Nucl Med Biol; 2018 Dec; 67():1-9. PubMed ID: 30317069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
    Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer's Disease.
    Shen Z; Bao X; Wang R
    Front Aging Neurosci; 2018; 10():314. PubMed ID: 30349474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models in neurological disorders: applications of non-invasive imaging.
    Waerzeggers Y; Monfared P; Viel T; Winkeler A; Jacobs AH
    Biochim Biophys Acta; 2010 Oct; 1802(10):819-39. PubMed ID: 20471478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease.
    Higuchi M
    Curr Alzheimer Res; 2009 Apr; 6(2):137-43. PubMed ID: 19355848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPECT and PET imaging in Alzheimer's disease.
    Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
    Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.
    Venneti S; Lopresti BJ; Wiley CA
    Prog Neurobiol; 2006 Dec; 80(6):308-22. PubMed ID: 17156911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.